China probes against foreign pharma unfair: EU business lobby

BEIJING (Reuters) - Foreign pharmaceutical firms in China have been unfairly targeted by a string of investigations into bribery and price-fixing despite generally strong legal compliance, a European Union business lobby said on Thursday.